{"name":"Genovate Biotechnology Co., Ltd.,","slug":"genovate-biotechnology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Nidadd","genericName":"Nidadd","slug":"nidadd","indication":"Other","status":"phase_3"},{"name":"PMR Tablet 135 mg","genericName":"PMR Tablet 135 mg","slug":"pmr-tablet-135-mg","indication":"Other","status":"phase_1"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Abilify (aripiprazole)","genericName":"Abilify (aripiprazole)","slug":"abilify-aripiprazole","indication":"Schizophrenia","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Combigan Ophthalmic Solutiom","genericName":"Combigan Ophthalmic Solutiom","slug":"combigan-ophthalmic-solutiom","indication":"Glaucoma","status":"marketed"}]}],"pipeline":[{"name":"Abilify (aripiprazole)","genericName":"Abilify (aripiprazole)","slug":"abilify-aripiprazole","phase":"marketed","mechanism":"Aripiprazole is a partial agonist at dopamine D2 and serotonin 5-HT1A receptors that helps stabilize dopamine and serotonin activity in the brain.","indications":["Schizophrenia","Bipolar I disorder (acute manic and mixed episodes, and maintenance treatment)","Major depressive disorder (adjunctive treatment)","Autism spectrum disorder (irritability)","Tourette's disorder"],"catalyst":""},{"name":"Combigan Ophthalmic Solutiom","genericName":"Combigan Ophthalmic Solutiom","slug":"combigan-ophthalmic-solutiom","phase":"marketed","mechanism":"Combigan combines a beta-adrenergic antagonist and an alpha-2 adrenergic agonist to reduce intraocular pressure by decreasing aqueous humor production and increasing uveoscleral outflow.","indications":["Glaucoma","Ocular hypertension"],"catalyst":""},{"name":"Nidadd","genericName":"Nidadd","slug":"nidadd","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"PMR Tablet 135 mg","genericName":"PMR Tablet 135 mg","slug":"pmr-tablet-135-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE5YVWVJNnZZYUVKNEFGbVFFMXFTV29nS2NnRWhCU3VDbGNrT3QzVmRXUEFBMUNvTjdUSTVwVldLZXZUM1NRRWs1LU5wazdaSE5mOE9UYk52YUVXdlExdTdfMEluYU9DZw?oc=5","date":"2026-04-01","type":"pipeline","source":"GuruFocus","summary":"Stock List: Research Stocks from Around the World - GuruFocus","headline":"Stock List: Research Stocks from Around the World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNQWJJWkZMYVJVck4tOElDOTdyY1YxUDlrbzl1Q05yYURQeWNXV0FDUjZud0U2RjdYS0dMTW5fcWJCVTUyZ3ZCenQtQmtKcXQ0UXJYeFpGN0tWTFMwV1phOHZVbnV2eEdFaEE1QVRud3M1TEo4b0ctSHM2R2wzZzlmaEFVcHRPamhqNGRGNkZWTm5wcXlvMGpEbEI5SlVicFBZa3NCSnpZeDFWRjJH?oc=5","date":"2025-10-22","type":"pipeline","source":"全球醫療採購網","summary":"Synmosa Biopharma Launches Public Tender Offer for 15–30% Stake in Genovate Biotechnology with 30% Premium, Shaking Up Taiwan’s Established Pharma Sector｜Institute for Biotechnology and Medicine Indus","headline":"Synmosa Biopharma Launches Public Tender Offer for 15–30% Stake in Genovate Biotechnology with 30% Premium, Shaking Up T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE9hSFJrSGdZRmRtTTBQN19TSk1OTkYtWmJpc21uWmFXSmtQS2tkaTh4LV9tUktPNzY4dHpYaGMyMWRpNExsSGpFbDdJLTlrOXV6d3hfZg?oc=5","date":"2025-09-17","type":"pipeline","source":"Taiwan News","summary":"Taiwan's Synmosa Biopharma eyes up to 30% stake in Genovate Biotechnology - Taiwan News","headline":"Taiwan's Synmosa Biopharma eyes up to 30% stake in Genovate Biotechnology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE0tZnFVVk83bGxFamM5UHFvMGNhOFBRTlFrdi1yVWV3WmQ5aXNJV3NiMVEzdElsNzhaeEY2RWg2VU12R21WYU1MQmhhUWhUSkhDazlOR0pTSQ?oc=5","date":"2017-05-19","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Ma Kuang Healthcare Holding Limited (4139.TWO) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Ma Kuang Healthcare Holding Limited (4139.TWO) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"marketed":2,"phase_3":1,"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}